Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP · 5 quarters on record
This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in PROTARA THERAPEUTICS INC (TARA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 360,000 | — | 0% | 1.03% | $1.9M | $5.33 |
| 2025 Q3 | UNCHANGED | 360,000 | — | 0% | 1.54% | $1.6M | $4.35 |
| 2025 Q2 | UNCHANGED | 360,000 | — | 0% | 1.29% | $1.1M | $3.03 |
| 2025 Q1 | UNCHANGED | 360,000 | — | 0% | 1.82% | $1.5M | $4.26 |
As of 2025 Q4 — sorted by position size